OnCo
companiesCompany

Chai Discovery

Makes Chai-1 and Chai-2, open-weight structure models used for antibody and binder design.

Chai-1 (2024) matched AlphaFold 3 on many benchmarks with open weights for non-commercial use; Chai-2 (2025) reported zero-shot de novo antibody hit rates far above earlier methods.

Headquarters
San Francisco, CA, US
Type
ai software

Connected

3top

Pages like this

not linked directly; found by shared links